Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MADECASSOL 10MG DIN 00603694

Status: Cancelled Post Market
Holder: SYNTEX INC.
Molecule: CENTELLA

Health Canada record

Active ingredient(s)CENTELLA 10 MG
Dosage formTablet
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassHuman
ATC
Original market date13-Jul-1984
Current status date19-Aug-1999
SourceHealth Canada DPD

Establishment licence of the holder

Syntex S.A. — licence , not currently licensed, last inspection rating I (2025-11-11).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CENTELLA

DINProductCompanyFormStrengthStatus
00606073EQUIDERMA 89.5%DISPAR, DIVISION OF VÉTOQUINOL N.-A. INC.SprayCENTELLA 89.5 %Cancelled Post Market

International API supply for CENTELLA

5 active FDA Drug Master Files.

Request a quote for MADECASSOL 10MG

How to read a Canadian DIN record